Posts Tagged ‘hcq’

COVID-19 Drama — A Timeline of HCQ vs Remdesivir

July 27, 2020

Update December 30, 2021 — Japan’s Tokyo Medical Association urged doctors to prescribe Ivermectin. After all, the ‘miracle’ molecule was discovered in Japan. In about two months, the COVID mortality rate dropped to 1/day in a population 1/3rd that of the U.S. (U.S. mortality, 1400/day, 450X that of Japan).

Nebraska is about two months into Ivermectin approval, and is approaching cutting their mortality rate by 50%. Nebraska, population 2 million, is suffering 4 – 6 deaths per day.

Update October 14, 2021 — Nebraska AG approves out-patient ‘off label’ prescription of Hydroxychloroquine and Ivermectin.

Update February, 2021 — NIH’s website contains many studies supporting HCQ Therapy. Hydroxychloroquine was lambasted by Fauci, and Pres. Trump ridiculed and shamed in the media for lacking ‘science’ in his support of HCQ Therapy. Meanwhile, Fauci and Azar (a former big pharm president and lobbyist) pushed for billions in vaccine research while shutting down our economy and society . . . while countries like India, which prescribe Hydroxychloroquine, have mortality rates for COVID 20X LESS than the United States and suffer no restrictions of their society and marketplaces. There are many studies buried in NIH records supporting HCQ, with or without Zinc and AZT. One observes a suppression of ‘viral shedding,’ meaning those infected, treated with HCQ, do not infect others.

Update October 5, 2020 1700 COVID patients cured with Hydroxychloroquine. One hospitalization . . . ZERO mortalites . . . doctor claims 75%-80% of the 200,000 dead could have been saved if HCQ wasn’t banned in favor of an ‘unnecessary’ vaccine.

Update August 25, 2020 — Now, three states lift Hydroxychloroquine ban. Texas lifted the ban in May, Ohio in July, and now Minnesota in August.

Update August 23, 2020 — Senators challenge FDA.

Update August 20, 2020 — Second governor removes block on Hydroxychloroquine.

Update August 8, 2020 — Democratic New York City Councilman Paul Vallone credits hydroxychloroquine with saving his life as he fought against the lethal respiratory disease. Vallone, who represents Queens, told the New York Post that HCQ “basically saved me.”

Update August 4, 2020 — The American Association of Physicians and Surgeons vs. Federal Food and Drug Administration, CV-002493, was filed in a federal district court to force the FDA to reverse their removal of Emergency Use Authorization (use requested by Pres. Trump) of Hydroxychloroquine.

On Friday, July 31, 2020, the AAPS filed a Motion to Expedite Hearing or Ruling to schedule a hearing with oral arguments for the Injunction against the FDA. Here is the Motion:

Here is an open letter from the doctors involved in the Henry Ford study of clinical treatment records, explaining how real world data is as valuable scientifically as clinical trials. Of course, there is a Real World Data source of Hydroxychloroquine use based on 1.3 billion people, and that is HCQ use in India that over six months has a mortality rate 20X less than the U.S. where HCQ use is banned.

Dr. Simone Gold of America’s Frontline Doctors (fired, and her social sites removed from the Internet) speaks on The Blaze.

Rep. Louie Gohmert of Texas taking Hydroxychloroquine

* * *

The first cases of COVID-19 came from Wuhan, China in January, 2020. Dr. Didier Raoult, a renowned French microbiologist, began antiviral trials of Hydroxychloroquine in patients March 6, 2020 which concluded, “hydroxychloroquine is efficient in clearing viral nasopharyngeal carriage of SARS-CoV-2 in COVID-19 patients in only three to six days, in most patients.”

In the United States, primary physicians were prescribing Hydroxychloroquine (HCQ) and recommended early use to stop spread of the virus (shedding) in days, at the most thirty-seven days.

March 21, 2020 — “Mr. Trump carelessly broadcast enthusiasm for the drug March 21, declaring that hydroxychloroquine and the antibiotic azithromycin “have a real chance to be one of the biggest game changers in the history of medicine.” He suggested they be put in use “immediately,” and the Food and Drug Administration authorized emergency use against covid-19.”

March 21, 2020 — State boards of pharmacy begin restrictions on hydroxychloroquine (HCQ). Here is a list of each state’s updated policy. One concern was hoarding of HCQ putting lupus and arthritis patients at risk, but the U.S. had stockpiled millions of doses, and the therapeutic dose is for only one week.

March 30, 2020 — FDA approves off-label use (emergency use authorization) of Hydroxychloroquine. Out-Patient success of use reported by Doctors Didier Raoult (microbiologist/virologist) and Zelenko. Private physicians note rapid elimination of the virus in out-patient quarantine.

March 31, 2020 — The American Spectator reports on the efficacy of HCQ and reprinted excerpts from Dr. Didier Rauolt’s report on his success with the drug, and the entire March 23, 2020 letter from Dr. Zelenko that informed President Trump of his ‘anecdotal’ success on hundreds of patients.

June 4, 2020 — The Association of American Physicians and Surgeons, a 501(c)(6) out of Phoenix, AZ, sues the FDA for restricting prescription of HCQ.

June 15, 2020 — FDA revokes emergency off-label use of Hydroxychloroquine.

June 16, 2020 — New York Times reports on government in-fighting over millions of hydroxychloroquine tablets put into stockpile. But, contradicting the president’s trade advisor Peter Navarro, Secretary of Health and Human Services Alex Azar (an attorney and former president of Eli Lilly) revokes use of HCQ favoring a new drug, Remdesivir. (Remdesivir has been determined ineffective on the viral diseases it was designed for and has severe liver inflammation issues, but approved for emergency use for COVID-19. See also Wikipedia cited report.)
While HCQ was better known, has fewer side-effects, and costs about $20 a dose for out-patients, Remdesivir is untested and a therapeutic course costs $2,340/patient. Being intravenous, it requires expensive hospital care (an additional $13,000 from Medicare.)
“This is a Deep State blindside by bureaucrats who hate the administration they work for more than they’re concerned about saving American lives,” Peter Navarro, Mr. Trump’s trade adviser, who helped distribute 19 million hydroxychloroquine pills, fumed in an interview Monday night. Mr. Navarro insisted that the F.D.A. would have “blood on its hands” if any of those studies showed hydroxychloroquine was effective.
The article mentions Dr. Didier Raoult, a world-renowned virologist, and Dr. Zelenko, who have been reporting success prescribing hydroxychloroquine. See also

July 6, 2020 — This is one of many press releases on the Henry Ford Health system of in-hospital clinical trials required by the FDA for use of hydroxychloroquine and azithromycin. Was Peter Navarro right after all?

July 31,2020 — Dr. Fauci appeared before congress, and while he was a cheerleader for an effective vaccine by the end of the year (without guaranteeing safety due to rushed testing), he lambasted the Henry Ford Health System’s peer-reviewed study of over 2500 patients.

Fauci complained the study was flawed because patients received steroids and other treatment, which wasn’t true. The study only counted lower death rates in patients receiving only hydroxychloroquine. The study specified that, “13% of those treated with hydroxychloroquine alone died, compared to 26.4% not treated with the malaria drug.” [emphasis added]

Dr. Fauci complained that, “The Henry Ford Hospital study that was published was a non-controlled, retrospective cohort study that was confounded by a number of issues including the fact that many people who received hydroxychloroquine were also receiving cortical steroids, which we know from another study gives a clear benefit in reducing deaths with advanced disease. So that study is a flawed study.” Dr. Marcus Zervos, division head of Infectious Disease for the health system, who co-authored the study, said the findings were highly analyzed and peer-reviewed.


The U.S. economy is still suffering from quarantine and now faces a second bill on bailouts and unemployment compensation. And, yet, Hydroxychloroquine is still denied to patients when clinical trials prove it can stop viral spread in mere days (See Dr. Zelenko 5-day treatment) and prevent hospitalization. Instead, billions have been allocated for Remdesivir and as yet unproven vaccines.


I searched on-line for nations that approve Hydroxychloroquine for out-patient prescriptions. India permits primary physicians (does not limit to specialists) to prescribe HCQ for early treatment and its mortality rate is 0.002%. That is 20X better than 0.04% in the U.S.

However, the infection map shows greater transmission rates in high-population urban areas; and, India is only 30% urban compared to 80% in the United States. Adjusting to urban areas only, India still has a mortality rate 7X less than the U.S. The lawsuit filed against the FDA cites a 10X lower mortality rate for all nations approving HCQ.

With 1.3 billion people, compared to 330 million in the U.S., India provides a real-world clinical trial of substantial statistical value.


Why is a $20 dose of a proven drug, Hydroxychloroquine, still barred from efficacious early treatment in favor of BILLIONS of DOLLARS spent on an unproven antiviral (Remdevisir) and rushed, untested vaccines that won’t be available until, perhaps, too late! Too late for many, already.

Many of the links are from conservative or religious news sites, however this situation is also covered by Reuters, The American Spectator, and the New York Times. However, the media is supporting Dr. Fauci’s position and continuing to ridicule President Trump which is acerbating ad extending the COVID-19 Pandemic into a catastrophic impact on our economy and 2020 national elections.

Dr. Zelenko’s 100% success with early prescription to any patient with breathing issues and testing positive for the virus moved him to encourage the president to distribute HCQ nationwide to end the epidemic as soon as possible. Dr. Fauci and the FDA have blocked this.

Leonard A. Daneman, Paralegal, Ret.

Full URL’s

March 21

March 30

June 4,U.S.%20doctors%20group%20sues%20FDA%20for%20limiting%20access%20to,by%20Trump%20for%20COVID%2D19&text=That%20harms%20the%20rights%20of,federal%20district%20court%20on%20Tuesday.

June 16

July 6

July 31